Agamia, Naglaa et al. published their research in Dermatologic Therapy in 2022 | CAS: 70359-46-5

5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate (cas: 70359-46-5) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. The antitumoral properties of quinoxaline compounds have been of interest. Recently, quinoxaline and its analogs have been investigated as the catalyst’s ligands.HPLC of Formula: 70359-46-5

A split face comparative study using a novel triple combination therapy for the treatment of persistent post acne erythema was written by Agamia, Naglaa;El-Nagdy, Sara;El-Ariny, Aly. And the article was included in Dermatologic Therapy in 2022.HPLC of Formula: 70359-46-5 This article mentions the following:

Persistent post acne erythema (PAE) is common cosmetically unacceptable and challenging sequelae of acne lesions. Tranexamic acid (TXA) is an antifibrinolytic agent that shows a pos. effect on wound healing in several studies, and it showed benefits in treating skin diseases like melasma, rosacea erythema and UV induced pigmentations. Oxymetazoline (OXZ) is a synthetic, highly selective agonist for alpha 1A-adrenoceptor. It is a potent vasoconstrictor. OXZ hydrochloride 1% cream was approved by the FDA in Jan. 2017 as a topical treatment for persistent facial erythema in rosacea patients. Brimonidine tartrate (BMT) is highly selective 伪2 adrenergic receptor agonist, results in direct, potent vasoconstriction of small arterioles and veins. In 2013, brimonidine 0.33% gel was the first topical therapy to be FDA approved for the treatment of persistent facial erythema from rosacea. To evaluate the efficacy and safety of topical triple combination (TXA 5% + OXZ 1.5% + BMT 0.33%) in the treatment of PAE planned as split face comparative study. This study was conducted on 40 patients diagnosed with persistent PAE for at least 3 mo, the right side of the face was treated with topical triple combination in liposomal base and was compared to the left side to which topical lipocream (placebo) was applied as a control. Our treatment plan lasted for 3 mo. According to the investigators global assessment of photographs and computerized anal. of erythema using image anal. software, topical triple combination applied on the right side of face was significantly effective in diminishing PAE when compared to topical placebo left side. Topical triple combination is a safe and cost-effective treatment for PAE. In the experiment, the researchers used many compounds, for example, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate (cas: 70359-46-5HPLC of Formula: 70359-46-5).

5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate (cas: 70359-46-5) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. The antitumoral properties of quinoxaline compounds have been of interest. Recently, quinoxaline and its analogs have been investigated as the catalyst’s ligands.HPLC of Formula: 70359-46-5

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Cho, Hyunsu et al. published their research in Organic Electronics in 2022 | CAS: 105598-27-4

Dipyrazino[2,3-f:2′,3′-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile (cas: 105598-27-4) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Product Details of 105598-27-4

Organic light-emitting diode structure for high color gamut in high-resolution microdisplay: Over 90% color gamut based on BT.2020 was written by Cho, Hyunsu;Joo, Chul Woong;Choi, Sukyung;Kang, Chan-mo;Kwon, Byoung-Hwa;Shin, Jin-Wook;Kim, Kukjoo;Ahn, Dae Hyun;Cho, Nam Sung. And the article was included in Organic Electronics in 2022.Product Details of 105598-27-4 This article mentions the following:

To implement primary colors in high-resolution organic light-emitting diode (OLED) microdisplays, color filters or cavity structures are applied to white OLEDs (WOLEDs). In terms of the high luminance and high color gamut required by microdisplays, two methods were exptl. compared in this study. In addition, a method for applying a color filter to WOLEDs with high-order cavity structures is proposed. The luminance of the proposed structure is lower than that of the cavity-only structure, but is similar to that obtained by applying a color filter to normal WOLEDs. Although previous methods do not satisfy the BT.2020 standard, the proposed structure achieves 90.8% of the BT.2020 standard In the experiment, the researchers used many compounds, for example, Dipyrazino[2,3-f:2′,3′-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile (cas: 105598-27-4Product Details of 105598-27-4).

Dipyrazino[2,3-f:2′,3′-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile (cas: 105598-27-4) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Product Details of 105598-27-4

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Li, Jing et al. published their research in Tetrahedron Letters in 2022 | CAS: 1196-57-2

2-Quinoxalinol (cas: 1196-57-2) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Quality Control of 2-Quinoxalinol

Direct C3-H carbamoylation of quinoxalin-2(1H)-ones with isocyanides enabled by selectfluor II under mild conditions was written by Li, Jing;Hu, Jie;Xiao, Yao;Yin, Kun;Dan, Wenyan;Fan, Suhua;Jin, Feng;Wu, Hai;Zhang, Ronghua;Li, Jian. And the article was included in Tetrahedron Letters in 2022.Quality Control of 2-Quinoxalinol This article mentions the following:

A F reagent-mediated direct C-H carbamoylation of quinoxalin-2(1H)-ones had been developed. Under room temperature, a variety of isocyanides were employed to couple well with quinoxalin-2(1H)-ones affording alkyl-oxo-quinoxaline-carboxamide I [R1 = H, Me, Ph, etc.; R2 = t-Bu, Bn, 1-naphthyl, etc.; R3 = H, 7-Ph, 6,7-di-Me, etc.]. This metal-free mild strategy tolerated a wide range of functional groups and shows environmental friendliness and practicality. In the experiment, the researchers used many compounds, for example, 2-Quinoxalinol (cas: 1196-57-2Quality Control of 2-Quinoxalinol).

2-Quinoxalinol (cas: 1196-57-2) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Quality Control of 2-Quinoxalinol

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Xu, Jun et al. published their research in Journal of Organic Chemistry in 2021 | CAS: 55687-34-8

6-Bromoquinoxalin-2(1H)-one (cas: 55687-34-8) belongs to quinoxaline derivatives. Quinoxalines are important class of heterocyclic compounds, associated with wider pharmacological applications. Quinoxalines are used in the treatment of bacterial, cancer, and HIV infections. Moreover, varenicline, a clinical drug is used for treating nicotine addiction, also contains quinoxaline moiety.Reference of 55687-34-8

Photo-Induced Cross-Dehydrogenative Alkylation of Heteroarenes with Alkanes under Aerobic Conditions was written by Xu, Jun;Cai, Heng;Shen, Jiabin;Shen, Chao;Wu, Jie;Zhang, Pengfei;Liu, Xiaogang. And the article was included in Journal of Organic Chemistry in 2021.Reference of 55687-34-8 This article mentions the following:

A Minisci-type cross-dehydrogenative alkylation in an aerobic atm. using abundant and inexpensive cerium chloride as a photocatalyst and air as an oxidant was reported. This photoreaction exhibited excellent tolerance to functional groups and was suitable for both heteroarene and alkane substrates under mild conditions, generating the corresponding products in moderate-to-good yields. This method provided an alternative approach for the late-stage functionalization of valuable substrates. In the experiment, the researchers used many compounds, for example, 6-Bromoquinoxalin-2(1H)-one (cas: 55687-34-8Reference of 55687-34-8).

6-Bromoquinoxalin-2(1H)-one (cas: 55687-34-8) belongs to quinoxaline derivatives. Quinoxalines are important class of heterocyclic compounds, associated with wider pharmacological applications. Quinoxalines are used in the treatment of bacterial, cancer, and HIV infections. Moreover, varenicline, a clinical drug is used for treating nicotine addiction, also contains quinoxaline moiety.Reference of 55687-34-8

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Sirvio, J. et al. published their research in Neuroscience (Oxford) in 1996 | CAS: 154235-83-3

Piperidin-1-yl(quinoxalin-6-yl)methanone (cas: 154235-83-3) belongs to quinoxaline derivatives. Quinoxalines have received a significant amount of attention due to their potential use in fighting various pathophysiological conditions like epilepsy, Parkinson鈥檚, and Alzheimer鈥檚 diseases. The parent substance of the group, quinoxaline, results when glyoxal is condensed with 1,2-diaminobenzene. Substituted derivatives arise when 伪-ketonic acids, 伪-chlorketones, 伪-aldehyde alcohols and 伪-ketone alcohols are used in place of diketones.Electric Literature of C14H15N3O

Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit was written by Sirvio, J.;Larson, J.;Quach, C. N.;Rogers, G. A.;Lynch, G.. And the article was included in Neuroscience (Oxford) in 1996.Electric Literature of C14H15N3O This article mentions the following:

The effects of a recently synthesized benzoyl-piperidine drug that enhances currents mediated by 伪-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)-type glutamate receptors were tested on monosynaptic and polysynaptic responses in hippocampal slices of the rat. Stimulation of perforant path inputs to the dentate gyrus evoked extracellular responses in field CA1 that had latencies and laminar profiles indicating that they were relayed through the trisynaptic intrahippocampal circuit. Under control conditions, trisynaptic field excitatory postsynaptic potentials did not show larger pair-pulse facilitation than monosynaptic responses and failed to exhibit frequency facilitation. Low concentrations of picrotoxin greatly enhanced trisynaptic responses and, under these conditions, frequency facilitation was obtained. Benzoyl-piperidine-12 (250 渭M) had a three-fold greater effect on the amplitude of trisynaptic responses than on monosynaptic field excitatory postsynaptic potentials, indicating that the drug’s effect is amplified across the successive stages of a polysynaptic circuit. The AMPA receptor modulator did not change the frequency characteristics of monosynaptic potentials and had only a modest influence on those of the trisynaptic response. The effect of benzoyl-piperidine-12 on trisynaptic responses was significantly greater when GABAergic inhibition was partially blocked with picrotoxin; the GABA blocker did not alter the effects of benzoyl-piperidine-12 on monosynaptic responses. These results indicate that centrally active AMPA receptor modulators are likely to have a greater influence on brain operations involving long chains of connections than on those mediated by simple reflex-like circuits, and will vary markedly in their effects depending upon the excitability of local interneurons. In the experiment, the researchers used many compounds, for example, Piperidin-1-yl(quinoxalin-6-yl)methanone (cas: 154235-83-3Electric Literature of C14H15N3O).

Piperidin-1-yl(quinoxalin-6-yl)methanone (cas: 154235-83-3) belongs to quinoxaline derivatives. Quinoxalines have received a significant amount of attention due to their potential use in fighting various pathophysiological conditions like epilepsy, Parkinson鈥檚, and Alzheimer鈥檚 diseases. The parent substance of the group, quinoxaline, results when glyoxal is condensed with 1,2-diaminobenzene. Substituted derivatives arise when 伪-ketonic acids, 伪-chlorketones, 伪-aldehyde alcohols and 伪-ketone alcohols are used in place of diketones.Electric Literature of C14H15N3O

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Ying, Lei et al. published their research in Macromolecular Chemistry and Physics in 2009 | CAS: 536753-86-3

2-Methyldibenzo[f,h]quinoxaline (cas: 536753-86-3) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including antibacterial, antibiotic and antineoplastic, antifungal, anti-inflammatory and analgesic drugs. Quinoxalines are used as dyes, pharmaceuticals, and antibiotics such as echinomycin, levomycin exhibiting antitumoral properties. Quinoxalines establish also the basis of anthelmintics and receptor antagonists.Computed Properties of C17H12N2

Novel red light-emitting fluorene-alt-carbazole copolymers with carbazole N-graft cyclometalated Ir complexes was written by Ying, Lei;Zou, Jianhua;Yang, Wei;Wu, Hongbin;Zhang, Anqi;Wu, Zhonglian;Cao, Yong. And the article was included in Macromolecular Chemistry and Physics in 2009.Computed Properties of C17H12N2 This article mentions the following:

A series of electrophosphorescent fluorene-alt-carbazole copolymers are synthesized by Suzuki polycondensation. A 尾-diketone-terminated alkyl chain grafted to the N-position of carbazole serves as a ligand to form a pendant cyclometalated Ir complex with 10-methyl-dibenzo[a,c]phenazine (Mpq), 2,3-diphenylquinoxaline (Bpq), and 1-(benzo[b]thiophen-2-yl)isoquinoline (Biq), resp. The emission of the device of PFCzIrBiq peaked at 715 and 790 nm, which is among the deepest red emissions reported so far. The well-achieved device performances could be attributed to a combination of a higher triplet energy and suitable HOMO/LUMO energy levels which can assure efficient charge injection as a result of the incorporation of a 3,6-carbazole unit into a polyfluorene backbone. In the experiment, the researchers used many compounds, for example, 2-Methyldibenzo[f,h]quinoxaline (cas: 536753-86-3Computed Properties of C17H12N2).

2-Methyldibenzo[f,h]quinoxaline (cas: 536753-86-3) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including antibacterial, antibiotic and antineoplastic, antifungal, anti-inflammatory and analgesic drugs. Quinoxalines are used as dyes, pharmaceuticals, and antibiotics such as echinomycin, levomycin exhibiting antitumoral properties. Quinoxalines establish also the basis of anthelmintics and receptor antagonists.Computed Properties of C17H12N2

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Yamamoto, Takakazu et al. published their research in Journal of the American Chemical Society in 1996 | CAS: 55687-34-8

6-Bromoquinoxalin-2(1H)-one (cas: 55687-34-8) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Related Products of 55687-34-8

Preparation of New Electron-Accepting 蟺-Conjugated Polyquinoxalines. Chemical and Electrochemical Reduction, Electrically Conducting Properties, and Use in Light-Emitting Diodes was written by Yamamoto, Takakazu;Sugiyama, Kiyoshi;Kushida, Takashi;Inoue, Tetsuji;Kanbara, Takaki. And the article was included in Journal of the American Chemical Society in 1996.Related Products of 55687-34-8 This article mentions the following:

Dehalogenation polycondensation of 5,8-dibromoquinoxaline derivatives and 2,6-dibromoquinoxaline with zero-valent Ni complex gives a series of 蟺-conjugated polyquinoxalines with mol. weight of 6 脳 103-260 脳 103. The polymers are electrochem. reduced (or n-doped) with an E掳 value of -1.75 to -2.35 V vs Ag/Ag+ and converted into elec. conducting materials with a conductivity of 1 脳 10-4 to 7 脳 10-3 S cm-1 by chem. reduction Poly(quinoxaline-5,8-diyl)s with aromatic substituents give strong fluorescence with emission peaks at 450-520 nm in solutions as well as in cast films. A light-emitting diode (LED), ITO/polymer/Mg(Ag) (polymer = poly(2,3-diphenylquinoxaline-5,8-diyl)), emits blue-green light (位max at about 500 nm). Introduction of hole-transporting layers such as vacuum-deposited or spin-coated thin layers of poly(thiophene-2,5-diyl), poly(p-phenylene), and poly(N-vinylcarbazole) between ITO and the light-emitting layer enhances electroluminescence efficiency by about 2 orders of magnitude. Polyquinoxalines have an ionization potential of 5.83 卤 0.11 eV and a band gap of 2.56 卤 0.26 eV. In the experiment, the researchers used many compounds, for example, 6-Bromoquinoxalin-2(1H)-one (cas: 55687-34-8Related Products of 55687-34-8).

6-Bromoquinoxalin-2(1H)-one (cas: 55687-34-8) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Related Products of 55687-34-8

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Hatakeyama-Sato, Kan et al. published their research in Batteries & Supercaps in 2022 | CAS: 2213-63-0

2,3-Dichloroquinoxaline (cas: 2213-63-0) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including as well as for RNA synthesis inhibition, reactive dyes and pigments, azo dyes, flurox Cylin Dyes, Corrosion Inhibitors and Photovoltaic Polymers. Quinoxaline-1,4-di-N-oxide derivatives have shown to improve the biological results and are endowed with anti-viral, anti-cancer, anti-bacterial, and anti-protozoal activities with application in many other therapeutic areas.Electric Literature of C8H4Cl2N2

Quadruply Fused Aromatic Heterocycles toward 4 V-Class Robust Organic Cathode-Active Materials was written by Hatakeyama-Sato, Kan;Go, Choitsu;Akahane, Tomoki;Kaseyama, Takahiro;Yoshimoto, Takuji;Oyaizu, Kenichi. And the article was included in Batteries & Supercaps in 2022.Electric Literature of C8H4Cl2N2 This article mentions the following:

Quadruply fused aromatic heterocycles are examined as 4 V-class organic cathode-active materials. A newly synthesized dimethylfluoflavin-substituted polymer displays reversible charge/discharge at high potentials of 3.5 and 4.1 V (vs. Li/Li+) as a cathode-active material for organic secondary batteries. The robust redox-active heterocycles enable the long cycle-life (>1000) while maintaining the high potential over 4 V. The linear polymer backbone and radical spin configuration in the heterocycles are the keys to enhancing the voltages and the cycle life. In the experiment, the researchers used many compounds, for example, 2,3-Dichloroquinoxaline (cas: 2213-63-0Electric Literature of C8H4Cl2N2).

2,3-Dichloroquinoxaline (cas: 2213-63-0) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including as well as for RNA synthesis inhibition, reactive dyes and pigments, azo dyes, flurox Cylin Dyes, Corrosion Inhibitors and Photovoltaic Polymers. Quinoxaline-1,4-di-N-oxide derivatives have shown to improve the biological results and are endowed with anti-viral, anti-cancer, anti-bacterial, and anti-protozoal activities with application in many other therapeutic areas.Electric Literature of C8H4Cl2N2

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Nasielski-Hinkens, Raymonde et al. published their research in Heterocycles in 1987 | CAS: 113269-08-2

6-Fluoro-7-nitroquinoxaline (cas: 113269-08-2) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Quinoxalines are used as dyes, pharmaceuticals, and antibiotics such as echinomycin, levomycin exhibiting antitumoral properties. Quinoxalines establish also the basis of anthelmintics and receptor antagonists.Related Products of 113269-08-2

The four 6-halo-7-nitroquinoxalines was written by Nasielski-Hinkens, Raymonde;Leveque, Pierre;Castelet, Daniel;Nasielski, Jacques. And the article was included in Heterocycles in 1987.Related Products of 113269-08-2 This article mentions the following:

The cyclocondensation of phenylenediamines I (R1 = F, Cl, Br, iodo) with glyoxal gave quinoxalines II. I were prepared from 4-halo-1,2-benzenediamines by successive N-tosylation, nitration, and detosylation. In the experiment, the researchers used many compounds, for example, 6-Fluoro-7-nitroquinoxaline (cas: 113269-08-2Related Products of 113269-08-2).

6-Fluoro-7-nitroquinoxaline (cas: 113269-08-2) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Quinoxalines are used as dyes, pharmaceuticals, and antibiotics such as echinomycin, levomycin exhibiting antitumoral properties. Quinoxalines establish also the basis of anthelmintics and receptor antagonists.Related Products of 113269-08-2

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Neri, Jannyely M. et al. published their research in Arabian Journal of Chemistry in 2020 | CAS: 2213-63-0

2,3-Dichloroquinoxaline (cas: 2213-63-0) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Related Products of 2213-63-0

2,3-Dichloroquinoxaline as a versatile building block for heteroaromatic nucleophilic substitution: A review of the last decade was written by Neri, Jannyely M.;Cavalcanti, Livia N.;Araujo, Renata M.;Menezes, Fabricio G.. And the article was included in Arabian Journal of Chemistry in 2020.Related Products of 2213-63-0 This article mentions the following:

An overview of the last decade on the remarkable versatility of DCQX as a substrate for SNAr reactions is described. Several examples in which DCQX reacts with N-, O-, S-, P- and C-nucleophiles, including controlled processes for the selective formation of mono- and disubstituted substrates are provided. Almost all polyfunctionalized quinoxalines synthesized using this approach have shown applications in different areas such as in biol. and technol. fields. In the experiment, the researchers used many compounds, for example, 2,3-Dichloroquinoxaline (cas: 2213-63-0Related Products of 2213-63-0).

2,3-Dichloroquinoxaline (cas: 2213-63-0) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Related Products of 2213-63-0

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider